Hypersensitivity pneumonitis pathophysiology

Hypersensitivity pneumonitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypersensitivity pneumonitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hypersensitivity pneumonitis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypersensitivity pneumonitis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypersensitivity pneumonitis pathophysiology

CDC on Hypersensitivity pneumonitis pathophysiology

Hypersensitivity pneumonitis pathophysiology in the news

Blogs on Hypersensitivity pneumonitis pathophysiology

Directions to Hospitals Treating Hypersensitivity pneumonitis

Risk calculators and risk factors for Hypersensitivity pneumonitis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Contents

* 1 Overview
* 2 Pathophysiology
* 2.1 Acute HP
* 2.2 Subacute or intermittent HP
* 2.3 Chronic HP
* 2.4 Immune Response
* 3 References

## Overview

[edit | edit source]

Hypersensitivity pneumonitis involves inhalation of organic dusts which act as an antigen. This leads to an exaggerated immune response, which is called hypersensitivity reactions. In hypersensitivity pneumonitis, its either Type III hypersensitivity or type IV hypersensitivity.

## Pathophysiology

[edit | edit source]

### Acute HP

[edit | edit source]

There are noncaseating interstitial granulomas and mononuclear cell infiltration in a peribronchial distribution. Giant cells are prominent.

### Subacute or intermittent HP

[edit | edit source]

The noncaseating granulomas are more well formed. There is bronchiolitis with or without organizing pneumonia. Interstitial fibrosis is present.

### Chronic HP

[edit | edit source]

There is chronic interstitial inflammation and alveolar destruction (honeycombing). There is dense fibrosis. The pathologic findings of chronic HP that are often associated with a poorer prognosis include the following 3 patterns of fibrosis:

* Predominantly peripheral fibrosis: in a patchy pattern with architectural distortion and fibroblast foci similar to usual interstitial pneumonia (UIP)

* Homogeneous linear fibrosis: similar to fibrotic nonspecific interstitial pneumonia (NSIP)

* Irregular predominantly peribronchiolar fibrosis

### Immune Response

[edit | edit source]

Exposure results in the development of circulating immunoglobulin G antibodies that are specific for the offending antigen. This antibody that forms is called the precipitating antibody, and it reacts with the specific putative antigen to form a precipitant. Initially the disease process was thought to be immunecomplex-mediated. However, subsequent studies have demonstrated that cell-mediated immunity is more important.

In the acute phase, there is a local increase in neutrophils in the alveoli and small airways. This is followed by an influx of mononuclear cells which release proteolytic enzymes, prostaglandins, and leukotrienes.

## References

[edit | edit source]

Template:WikiDoc Sources